JP2006511476A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006511476A5 JP2006511476A5 JP2004538153A JP2004538153A JP2006511476A5 JP 2006511476 A5 JP2006511476 A5 JP 2006511476A5 JP 2004538153 A JP2004538153 A JP 2004538153A JP 2004538153 A JP2004538153 A JP 2004538153A JP 2006511476 A5 JP2006511476 A5 JP 2006511476A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- compound
- integer
- methyl
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 23
- 150000003839 salts Chemical class 0.000 claims 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 6
- 125000004432 carbon atom Chemical group C* 0.000 claims 5
- 239000000460 chlorine Substances 0.000 claims 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- 229910052731 fluorine Inorganic materials 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical group C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 2
- -1 2-chloro-4- {4-cycloheptylamino-6- [methyl- (1-methyl-piperidin-4-yl) amino] -1,3,5-triazin-2-yl} -aminophenol Chemical compound 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 229910052744 lithium Inorganic materials 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25338802A | 2002-09-23 | 2002-09-23 | |
| US10/390,485 US7173032B2 (en) | 2001-09-21 | 2003-03-17 | Methods and compositions of novel triazine compounds |
| PCT/US2003/009356 WO2004026844A1 (en) | 2002-09-23 | 2003-03-26 | Methods and compositions of novel triazine compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006079816A Division JP2006188533A (ja) | 2002-09-23 | 2006-03-22 | 新規トリアジン化合物の組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006511476A JP2006511476A (ja) | 2006-04-06 |
| JP2006511476A5 true JP2006511476A5 (https=) | 2006-05-25 |
Family
ID=32033248
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004538153A Pending JP2006511476A (ja) | 2002-09-23 | 2003-03-26 | 新規トリアジン化合物の組成物および方法 |
| JP2006079816A Pending JP2006188533A (ja) | 2002-09-23 | 2006-03-22 | 新規トリアジン化合物の組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006079816A Pending JP2006188533A (ja) | 2002-09-23 | 2006-03-22 | 新規トリアジン化合物の組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7173032B2 (https=) |
| EP (1) | EP1560817A4 (https=) |
| JP (2) | JP2006511476A (https=) |
| AU (1) | AU2003231975A1 (https=) |
| BR (1) | BR0314670A (https=) |
| CA (1) | CA2499964A1 (https=) |
| RU (1) | RU2005108351A (https=) |
| WO (1) | WO2004026844A1 (https=) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
| US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
| PL366250A1 (en) * | 2000-12-29 | 2005-01-24 | Reddy Us Therapeutics, Inc. | Detection of compounds that modulate inflammatory responses |
| US7173032B2 (en) | 2001-09-21 | 2007-02-06 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7163943B2 (en) * | 2001-09-21 | 2007-01-16 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7112587B2 (en) * | 2001-09-21 | 2006-09-26 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7169785B2 (en) * | 2001-09-21 | 2007-01-30 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7307079B2 (en) * | 2002-05-30 | 2007-12-11 | Solvay Pharmaceuticals, B.V. | 1,3,5-Triazine derivatives as ligands for human adenosine-A3 receptors |
| US20040167132A1 (en) * | 2003-01-16 | 2004-08-26 | Geetha Shankar | Methods of treating conditions associted with an Edg-2 receptor |
| US7557129B2 (en) * | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| US7335770B2 (en) * | 2004-03-24 | 2008-02-26 | Reddy U5 Therapeutics, Inc. | Triazine compounds and their analogs, compositions, and methods |
| US7862835B2 (en) * | 2004-10-27 | 2011-01-04 | Boston Scientific Scimed, Inc. | Method of manufacturing a medical device having a porous coating thereon |
| ITMI20050222A1 (it) * | 2005-02-15 | 2006-08-16 | Milano Politecnico | Lipidi cationici per la trasfezione di acidi nucleici |
| US20090012148A1 (en) * | 2005-11-01 | 2009-01-08 | Maxfield Frederick R | Reducing cellular cholesterol levels and/or treating or preventing phospholipidosis |
| US8637436B2 (en) | 2006-08-24 | 2014-01-28 | California Institute Of Technology | Integrated semiconductor bioarray |
| US11098345B2 (en) * | 2006-06-05 | 2021-08-24 | California Institute Of Technology | Methods for detecting target analytes |
| US11001881B2 (en) * | 2006-08-24 | 2021-05-11 | California Institute Of Technology | Methods for detecting analytes |
| US11525156B2 (en) | 2006-07-28 | 2022-12-13 | California Institute Of Technology | Multiplex Q-PCR arrays |
| US8048626B2 (en) | 2006-07-28 | 2011-11-01 | California Institute Of Technology | Multiplex Q-PCR arrays |
| EP2441757A1 (en) | 2006-07-31 | 2012-04-18 | Praecis Pharmaceuticals Incorporated | Aurora kinase inhibitors from an encoded small molecule library |
| EP2059512A1 (en) * | 2006-08-01 | 2009-05-20 | Praecis Pharmaceuticals Incorporated | P38 kinase inhibitors |
| US11560588B2 (en) | 2006-08-24 | 2023-01-24 | California Institute Of Technology | Multiplex Q-PCR arrays |
| WO2008137533A1 (en) * | 2007-05-04 | 2008-11-13 | Reddy Us Therapeutics, Inc. | Methods and compositions for upregulation of gata activity |
| JP2012529512A (ja) * | 2009-06-08 | 2012-11-22 | アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー | トリアジン誘導体類及びそれらの治療応用 |
| US8927547B2 (en) | 2010-05-21 | 2015-01-06 | Noviga Research Ab | Pyrimidine derivatives |
| KR20120011667A (ko) * | 2010-07-29 | 2012-02-08 | 광주과학기술원 | 당뇨병 치료제의 스크리닝 방법 |
| JP6184866B2 (ja) * | 2010-10-27 | 2017-08-23 | ウォルター アンド エリザ ホール インスティテュート オブ メディカル リサーチ | 新規抗がん剤 |
| US8877221B2 (en) | 2010-10-27 | 2014-11-04 | Warsaw Orthopedic, Inc. | Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same |
| US9107983B2 (en) | 2010-10-27 | 2015-08-18 | Warsaw Orthopedic, Inc. | Osteoconductive matrices comprising statins |
| DK2688883T3 (en) | 2011-03-24 | 2016-09-05 | Noviga Res Ab | pyrimidine |
| US9308190B2 (en) | 2011-06-06 | 2016-04-12 | Warsaw Orthopedic, Inc. | Methods and compositions to enhance bone growth comprising a statin |
| WO2013047411A1 (ja) * | 2011-09-29 | 2013-04-04 | 富士フイルム株式会社 | 新規なトリアジン誘導体、紫外線吸収剤 |
| US20150038511A1 (en) | 2012-08-09 | 2015-02-05 | Celgene Corporation | Treatment of immune-related and inflammatory diseases |
| LT2882441T (lt) | 2012-08-09 | 2020-07-27 | Celgene Corporation | Su imunitetu susijusių ir uždegiminių ligų gydymas |
| US9119606B2 (en) | 2013-01-21 | 2015-09-01 | Ethicon, Inc. | Sealant delivery device for anastomotic stapler |
| US10245266B2 (en) | 2014-05-19 | 2019-04-02 | Celgene Corporation | 3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus |
| TWI602951B (zh) * | 2014-08-13 | 2017-10-21 | 日本派克乃成股份有限公司 | 補給劑、表面處理金屬材料及其製造方法 |
| WO2016070241A1 (en) * | 2014-11-03 | 2016-05-12 | Ctxt Pty Ltd | Triazine compounds, compositions and synthesis |
| US9708647B2 (en) | 2015-03-23 | 2017-07-18 | Insilixa, Inc. | Multiplexed analysis of nucleic acid hybridization thermodynamics using integrated arrays |
| US9499861B1 (en) | 2015-09-10 | 2016-11-22 | Insilixa, Inc. | Methods and systems for multiplex quantitative nucleic acid amplification |
| WO2017155858A1 (en) | 2016-03-07 | 2017-09-14 | Insilixa, Inc. | Nucleic acid sequence identification using solid-phase cyclic single base extension |
| LT3483164T (lt) | 2017-03-20 | 2020-05-11 | Forma Therapeutics, Inc. | Pirolpirolo kompozicijos kaip piruvato kinazės (pkr) aktyvatoriai |
| EP3852791B1 (en) | 2018-09-19 | 2024-07-03 | Novo Nordisk Health Care AG | Activating pyruvate kinase r |
| EP3853206B1 (en) | 2018-09-19 | 2024-04-10 | Novo Nordisk Health Care AG | Treating sickle cell disease with a pyruvate kinase r activating compound |
| WO2020141439A1 (en) * | 2018-12-31 | 2020-07-09 | Integral Biosciences Private Limited | Heterocyclic compounds as mutant idh inhibitors |
| JP7687957B2 (ja) | 2019-03-14 | 2025-06-03 | インシリクサ， インコーポレイテッド | 時間ゲート蛍光ベースの検出のための方法およびシステム |
| HRP20251148T1 (hr) | 2019-09-19 | 2025-11-21 | Novo Nordisk Health Care Ag | Pripravci koji aktiviraju piruvat-kinazu r (pkr) |
| US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
| CN119462614B (zh) * | 2025-01-14 | 2025-05-02 | 吉林大学 | 1-mhmd、制备方法及其应用 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3290305A (en) | 1963-02-05 | 1966-12-06 | Goldschmidt Ag Th | Chloro-s-triazinyl-aminoacids |
| BE726947A (https=) | 1968-04-10 | 1969-07-01 | ||
| US3867383A (en) | 1971-03-29 | 1975-02-18 | Ciba Geigy Corp | Monoanthranilatoanilino-s-triazines |
| DE3206398A1 (de) | 1982-02-23 | 1983-09-01 | Basf Ag, 6700 Ludwigshafen | S-triazinderivate und ihre verwendung als lichtschutzmittel |
| GB8808071D0 (en) | 1988-04-07 | 1988-05-11 | Shell Int Research | Triazine herbicides |
| WO1991003511A1 (en) * | 1989-09-09 | 1991-03-21 | Sandoz Ltd | Synthetic polyamides and their salts |
| IT1255729B (it) | 1992-05-19 | 1995-11-15 | Giuseppe Raspanti | Derivati di s-triazina come agenti fotostabilizzanti |
| DE19531084A1 (de) | 1995-08-24 | 1997-02-27 | Hoechst Schering Agrevo Gmbh | 2,4-Diamino-1,3,5-triazine, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
| US6117996A (en) | 1995-09-20 | 2000-09-12 | Novo Nordisk A/S | Triazine based ligands and use thereof |
| GB9519197D0 (en) * | 1995-09-20 | 1995-11-22 | Affinity Chromatography Ltd | Novel affinity ligands and their use |
| IT1283295B1 (it) | 1996-03-22 | 1998-04-16 | 3V Sigma Spa | Filtri solari |
| US5801224A (en) | 1996-04-26 | 1998-09-01 | Board Of Trustees Operating Michigan State University | Bulk reactive extrusion polymerization process producing aliphatic ester polymer compositions |
| DE19641693A1 (de) * | 1996-10-10 | 1998-04-16 | Bayer Ag | Substituierte 2-Amino-4-alkylamino-1,3,5-triazine |
| US5759525A (en) | 1996-12-26 | 1998-06-02 | 3V Inc. | Concentrated solutions of a 1,3,5-triazine derivative sunscreen and their use for the preparation of cosmetic compositions |
| GB9726695D0 (en) | 1997-12-17 | 1998-02-18 | Smithkline Beecham Plc | Novel compounds |
| JPH11158073A (ja) * | 1997-09-26 | 1999-06-15 | Takeda Chem Ind Ltd | アデノシンａ３拮抗剤 |
| JP3518300B2 (ja) * | 1997-11-17 | 2004-04-12 | 東洋インキ製造株式会社 | 顔料分散剤、及びそれを含有する顔料組成物 |
| US6123763A (en) * | 1997-12-22 | 2000-09-26 | Toyo Ink Mfg. Co., Ltd. | Pigment dispersing agent and pigment composition containing the same |
| DE69814151T2 (de) | 1997-12-12 | 2004-03-25 | Abbott Laboratories, Abbott Park | Triazin angiogenese-inhibitoren |
| WO1999036410A1 (en) | 1998-01-13 | 1999-07-22 | Scriptgen Pharmaceuticals, Inc. | Triazine antiviral compounds |
| EP0945447A1 (en) * | 1998-03-27 | 1999-09-29 | Janssen Pharmaceutica N.V. | Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections |
| AU2623900A (en) * | 1999-01-22 | 2000-08-07 | American Home Products Corporation | Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| US6262053B1 (en) * | 1999-06-23 | 2001-07-17 | Parker Hughes Institute | Melamine derivatives as potent anti-cancer agents |
| SK7402002A3 (en) | 1999-11-29 | 2002-11-06 | Aventis Pharma Sa | Arylamine derivatives and their use as anti-telomerase agent |
| US6645964B1 (en) | 1999-11-29 | 2003-11-11 | Aventis Pharma S.A. | Chemical derivatives and their application as antitelomerase agent |
| US20020065270A1 (en) | 1999-12-28 | 2002-05-30 | Moriarty Kevin Joseph | N-heterocyclic inhibitors of TNF-alpha expression |
| EP1246823A1 (en) | 1999-12-28 | 2002-10-09 | Pharmacopeia, Inc. | Pyrimidine and triazine kinase inhibitors |
| US6491617B1 (en) | 1999-12-30 | 2002-12-10 | St. Jude Medical, Inc. | Medical devices that resist restenosis |
| FR2819255B1 (fr) * | 2001-01-09 | 2003-02-28 | Aventis Pharma Sa | Derives chimiques et leur application comme agent antitelomerase |
| CO5380035A1 (es) * | 2001-03-23 | 2004-03-31 | Aventis Pharma Sa | Derivados quimicos y su aplicacion como agente antitelomerasa |
| US7169785B2 (en) * | 2001-09-21 | 2007-01-30 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| WO2003024926A2 (en) | 2001-09-21 | 2003-03-27 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7163943B2 (en) * | 2001-09-21 | 2007-01-16 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7132423B2 (en) * | 2001-09-21 | 2006-11-07 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7173032B2 (en) * | 2001-09-21 | 2007-02-06 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7112587B2 (en) * | 2001-09-21 | 2006-09-26 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| KR100875362B1 (ko) * | 2002-02-05 | 2008-12-22 | 아스텔라스세이야쿠 가부시키가이샤 | 2,4,6-트리아미노-1,3,5-트리아진 유도체 |
-
2003
- 2003-03-17 US US10/390,485 patent/US7173032B2/en not_active Expired - Fee Related
- 2003-03-26 AU AU2003231975A patent/AU2003231975A1/en not_active Abandoned
- 2003-03-26 RU RU2005108351/04A patent/RU2005108351A/ru not_active Application Discontinuation
- 2003-03-26 EP EP03797788A patent/EP1560817A4/en not_active Withdrawn
- 2003-03-26 BR BR0314670-7A patent/BR0314670A/pt not_active IP Right Cessation
- 2003-03-26 CA CA002499964A patent/CA2499964A1/en not_active Abandoned
- 2003-03-26 US US10/528,724 patent/US7332489B2/en not_active Expired - Fee Related
- 2003-03-26 JP JP2004538153A patent/JP2006511476A/ja active Pending
- 2003-03-26 WO PCT/US2003/009356 patent/WO2004026844A1/en not_active Ceased
-
2006
- 2006-03-22 JP JP2006079816A patent/JP2006188533A/ja active Pending
- 2006-10-05 US US11/543,969 patent/US20070043051A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006511476A5 (https=) | ||
| RU2005108351A (ru) | Способы и композиции новых триазиновых соединений | |
| JP2021088610A5 (https=) | ||
| Kyba et al. | Host-guest complexation. 11. Survey of chiral recognition of amine and amino ester salts by dilocular bisdinaphthyl hosts | |
| EG16936A (en) | Process for preparing of piperidine derivatives and pharmaceutical compositions containing them | |
| NO164350C (no) | Azolylderivater, antisopp-preparater og anvendelse av forbindelsene for bekjempelse av soppinfeksjoner. | |
| JP2019500315A5 (https=) | ||
| JP2007501793A5 (https=) | ||
| JP2005525315A5 (https=) | ||
| JP2010530881A5 (https=) | ||
| JP2005514420A5 (https=) | ||
| JP2008533191A5 (https=) | ||
| PL409123A1 (pl) | Związki, ich zastosowanie i kompozycje do leczenia wirusowego zapalenia wątroby typu C | |
| JP2020536082A5 (https=) | ||
| RU95121694A (ru) | Применение аналогов ацилфульвена и фармацевтическая композиция на их основе | |
| JP2005536519A5 (https=) | ||
| JP2022505268A5 (https=) | ||
| JP2003508534A5 (https=) | ||
| WO2000032578A8 (en) | Benzimidazole compounds that are vitronectin receptor antagonists | |
| JP2002523496A5 (https=) | ||
| JP2003508513A5 (https=) | ||
| JP2002510689A5 (https=) | ||
| TW336929B (en) | Benzenesulphonamide derivatives, their preparation and their application in therapy | |
| CA2273894A1 (en) | Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use | |
| AR029072A1 (es) | Bis-(n,n'-bis-(2-haloetil)amino fosforamidatos, un procedimiento para su preparacion, una composicion farmaceutica, y el uso de los mismos para la manufactura de medicamentos antitumorales |